Why are three different longevity compounds included rather than selecting one?

Biological aging is driven by multiple parallel mechanisms, not a single cause. NAD+ addresses coenzyme-level decline and sirtuin activity. Epithalon addresses telomere shortening. MOTS-c addresses mitochondrial metabolic signaling. Studying all three together allows researchers to examine whether interventions at each level are additive, synergistic, or independent. Single-target approaches cannot capture interactions between aging mechanisms.

Which compound in the panel has the oldest research history?

NAD+ has by far the longest research history, as it is a fundamental coenzyme that has been studied in cellular biochemistry for over a century. Epithalon was developed by the Khavinson group in the 1980s and 1990s. MOTS-c was the most recently identified, with its discovery published by Lee et al. in Cell Metabolism in 2015. The panel thus combines a foundational biochemical target with a long-studied peptide and a recently characterized mitochondrial signaling molecule.

Is there published data on combining NAD+ with Epithalon or MOTS-c?

Direct combination studies in the published literature are limited. Most published research examines each compound in isolation. However, the mechanistic rationale for combining them is well-supported by the established biology: NAD+ and MOTS-c both converge on mitochondrial function from different directions, and Epithalon adds the telomere dimension that neither of the others addresses. Researchers designing combination protocols typically rely on this mechanistic complementarity in the absence of direct combination trial data.

Research Stack

Longevity Research Panel

NAD+, Epithalon, and MOTS-c for multi-hallmark aging biology research

The Longevity Research Panel combines three compounds that address three distinct hallmarks of biological aging as described in the geroscience literature. NAD+ addresses the coenzyme-level decline associated with sirtuin dysregulation, impaired DNA repair, and mitochondrial dysfunction. Epithalon addresses the telomere attrition hallmark via telomerase activation in somatic cell models. MOTS-c addresses mitochondrial dysfunction and metabolic dysregulation through AMPK-driven retrograde signaling from the mitochondria to the nucleus. Together, these three compounds allow researchers to study aging biology across the biochemical, telomere, and mitochondrial dimensions of the aging process in a single experimental design.

Stack Compounds

Each compound contributes a distinct mechanism to the combined research protocol.

NAD+

Addresses the sirtuin substrate and DNA repair dimension of aging by replenishing the coenzyme pool required for SIRT1 through SIRT7 activity and PARP-mediated DNA strand break repair.

$279

Epithalon

Addresses the telomere attrition dimension of aging by activating telomerase (hTERT) to maintain telomere length and extend replicative cell lifespan in somatic cell models.

$199

MOTS-c

Addresses the mitochondrial dysfunction and metabolic dysregulation dimension of aging by activating AMPK via retrograde mitochondrial signaling to restore metabolic flexibility and cellular energy homeostasis.

$149

Why This Combination Works

NAD+, Epithalon, and MOTS-c operate on non-redundant and complementary aging mechanisms. NAD+ functions as the upstream coenzyme that enables sirtuin and PARP activity. MOTS-c functions as a downstream mitochondrial signal that communicates metabolic status to the nucleus via AMPK. Epithalon operates at the telomere level, which is mechanistically distinct from both the mitochondrial and the coenzyme axes. Including all three in a single panel allows researchers to examine how these different hallmarks interact and whether modulating one axis influences the others.

Research Context

Multi-hallmark longevity research panels have become increasingly common as the field has moved beyond single-target interventions toward comprehensive aging models. The Lopez-Otin hallmarks of aging framework provides the theoretical basis for selecting compounds that address different biological aging mechanisms simultaneously. Each compound in this panel targets a different listed hallmark: NAD+ for epigenetic alterations and genomic instability, Epithalon for telomere attrition, and MOTS-c for mitochondrial dysfunction and deregulated nutrient sensing.

Related Compound Comparisons

Side-by-side mechanism comparisons for compounds in this stack.

NAD+ vs Epithalon →NAD+ vs MOTS-c →MOTS-c vs Epithalon →

Related Research Use Cases

Explore the broader research contexts this stack contributes to.

Longevity and Anti-Aging Research →

Frequently Asked Questions

Build This Stack

All compounds in this stack are available from Spartan Peptides at least 98% HPLC-verified purity. Domestic US supply with same-day dispatch before 2 PM. For in-vitro research use only.

NAD+ ($279)Epithalon ($199)MOTS-c ($149)

All compounds are strictly for in-vitro research use only and not intended for human consumption.

GLP-3(Reta) | Triple-Agonist Metabolic Research

NAD+ 750mg | Cellular Energy & DNA Repair Research

MOTS-c | Mitochondrial Metabolism Research Peptide

BPC-157 5mg | Tissue Repair & Gut Health Research